Close
FINDING CURES TOGETHER<sup>SM</sup>

​Science Policy Track: AACR Annual Meeting

The Science Policy track provides attendees with the opportunity to learn more about health and science policy issues affecting cancer research, patients, survivors, and families. The sessions are designed to highlight recent developments in science policy as they affect cancer research and provide an open forum for the discussion of health care policies that impact cancer patients and families.

2017      2016      2015

AACR Annual Meeting 2018 (Chicago)

How the AACR is Working for You in Washington: A Town Hall Meeting on Cancer Research Funding and Science Policy Initiatives

Watch the webcast.

George D. Demetri (Chair) - Dana-Farber Cancer Institute, Boston, Massachusetts
Kristin Anderson - Fred Hutchinson Cancer Research Center, Seattle, Washington
Beth Anne Baber - The Nicholas Conor Institute, San Diego, California
M.K. Holohan Quattrocchi - National Cancer Institute, Bethesda, Maryland
Mary Lee Watts - AACR, Washington, D.C.

The Cancer Survivorship Landscape: Potential Focus Areas for the Future

Watch the webcast.

Anna D. Barker (Moderator) - Arizona State University, Scottsdale, Arizona
Greg Aune - Children’s Cancer Research Institute, San Antonio, Texas
Shelley Fuld Nasso - National Coalition for Cancer Survivorship, Silver Spring, Maryland
Brenda Nevidjon - Oncology Nursing Society, Pittsburgh, Pennsylvania
Julia Rowland - National Cancer Institute, Bethesda, Maryland
Julie Silver - Harvard Medical School, Boston, Massachusetts
Patty Spears - UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
Doug Ulman - Pelotonia, Columbus, Ohio

A Town Hall Discussion of AACR's Priorities in Tobacco Policy

Watch the webcast.

Roy S. Herbst (Chair) - Yale Cancer Center, New Haven, Connecticut
Cathy L. Backinger - FDA, Silver Spring, Maryland
Michele Bloch - National Cancer Institute, Bethesda, Maryland
Dorothy K. Hatsukami - University of Minnesota, Minneapolis, Minnesota
Brian A. King - Centers for Disease Control and Prevention, Atlanta, Georgia
Christopher S. Lathan - Dana-Farber Cancer Institute, Boston, Massachusetts

NCI Director's Address and Fireside Chat with AACR Leaders

Watch the webcast.

Norman E. Sharpless - National Cancer Institute, Bethesda, Maryland
Fireside Chat
Michael A. Caligiuri - City of Hope National Medical Center, Duarte, California
Elizabeth M. Jaffee - Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland

Biden Cancer Initiative Colloquium

Watch the webcast.

Greg Simon - Biden Cancer Initiative, Washington, D.C.
Elizabeth M. Jaffee - Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, Maryland
Louis J. DeGennaro - The Leukemia & Lymphoma Society, Rye Brook, New York
Asif Dhar - Deloitte Consulting LLP, Rosslyn, Virginia
Patricia M. Doykos - Bristol-Myers Squibb, New York, New York
Stanton L. Gerson - Case Comprehensive Cancer Center, Cleveland, Ohio
Jay Holley - Uber Health, San Francisco, California
Carla Tardif - Family Reach, Boston, Massachusetts

Access to Health Care in the Era of Biologically Targeted Therapies

Watch the webcast.

Sara A. Hurvitz (Chair) - UCLA, Santa Monica, California
Justin Bekelman - Abramson Cancer Center of University of Pennsylvania, Philadelphia, Pennsylvania
Katherine Reeder-Hayes - University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Christopher S. Lathan - Dana-Farber Cancer Institute, Boston, Massachusetts

AACR Annual Meeting 2017 (Washington, D.C.)  

Beau Biden Cancer Moonshot: Progress and Promise

Watch Biden's speech. Watch the panel discussion.

Former Vice President Joe Biden delivered remarks during the Annual Meeting 2017. His remarks took place at the beginning of the “BeauBiden Cancer Moonshot: Progress and Promise,” session that involved leaders in government, academia, industry, and patient advocacy organizations discussing how the “Beau Biden Cancer Moonshot” provision that was included in the 21st Century Cures Act is stimulating the acceleration of progress against cancer and how it will result in better outcomes for patients. Vice President Biden’s remarks focused on the progress made as part of the Cancer Moonshot and his plans to keep up the fight as part of his Biden Cancer Initiative.

Biden’s remarks were followed by a panel discussion moderated by AACR President Dr. Nancy Davidson. The panel featured Elaine Chao, secretary of transportation; Fran Drescher, actress and founder of Cancer Schmancer; Dr. Richard Pazdur, director, FDA Oncology Center of Excellence; Dr. Douglas Lowy, acting director, NCI; Dr. Michael Caligiuri, AACR president-elect; and Dr. Elizabeth Jaffee, the AACR’s incoming president-elect, who served as co-chair of the Cancer Moonshot Blue Ribbon Panel.

The Potential Imp​act on Cancer Patients of a Repeal or Revision of the Affordable Care Act

Watch the webcast of this session.

The administration and Republican lawmakers have said that dismantling the Affordable Care Act (ACA) is a top priority in 2017. The ACA, which was signed into law in 2010 and implemented over the subsequent four years, has provided major benefits for cancer patients. This session will discuss some of the specific provisions in the ACA that are benefiting cancer patients, such as ensuring that individuals are covered for pre-existing conditions; access is provided to preventive services; annual and lifetime coverage caps are prohibited; and access to clinical trials is encouraged.

E-cigarettes: Are they a Public Health Threat or a Useful Cessation Tool?

Watch the webcast of this session.

This session​ will provide an opportunity to consider the different viewpoints on e-cigarettes, specifically whether they might act as a gateway to smoking for nonsmokers or be a useful public health tool to aid in smoking cessation. Additionally, there will be research updates on e-cigarettes related to their initiation, toxicity, and dependence, as well as possible use in tobacco treatment programs and secondhand vaping associated risks. The session will also cover research on nicotine and nicotinic receptors and flavor related e-cigarette use and updates on new generation products (e.g., heat not burn tobacco devices).

AACR Annual Meeting 2016 (New Orleans)  

Click each speaker's name to watch the recording of their presentation.​ (Note: Not all speakers have given permission to have their presentation recorded.)

The Impact of the Affordable Care Act (ACA) on Cancer Research, Care, and Prevention​
Sunday, April 17 | 11 a.m. - 12:30 p.m.
Gilbert S. Omenn (chair), William S. Dalton, Mary J. Scroggins, Ernest T. Hawk, and
Jennifer Singleterry​

The Intersection of Science Policy and Cancer Research: A Town Hall Meeting on the Administration's Special Cancer Research Initiative and AACR's Advocacy Efforts​
Sunday, April 17 | 1 - 2:30 p.m.
Roy A. Jensen (moderator), Jon G. Retzlaff, Mary Lee Watts, Lee D. Gibbs, and
Mary J. Scroggins

Tobacco Contr​ol Policy Session - the Need for ENDS Regulations: Public Health Concerns and Opportunities​
Sunday, April 17 | 3 - 4:30 p.m.
Roy S. Herbst (moderator), Peter G. Shields​, Brian A. King, Lauren Dutra​, and Ray Niaura


​AACR Annual Meeting 2015 (Philadelphia)  

Click each speaker's name to watch the recording of their presentation.​ (Note: Not all speakers have given permission to have their presentation recorded.)

The Intersection​ of Science Policy and Cancer Research: A Town Hall Meeting with the AACR Office of Science Policy and Government Affairs
Sunday, April 19, 2015
William S. Dalton, Jack Whelan, Jon G. Retzlaff​, Carrie Wolinetz, Mary Lee Watts

Tobacco Control and Electronic Nicotine Delivery Systems (ENDS)

Monday, April 20, 2015
Roy S. Herbst, Peter G. Shields, Rachel Grana, Danny McGoldrick  ​